|
Oct 2
|
Illumina, Inc. (ILMN): A Bull Case Theory
|
|
Sep 30
|
Shareholders in Illumina (NASDAQ:ILMN) are in the red if they invested three years ago
|
|
Sep 13
|
Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually
|
|
Sep 10
|
Illumina and Exxon Mobile have been highlighted as Zacks Bull and Bear of the Day
|
|
Sep 10
|
Bull of the Day: Illumina (ILMN)
|
|
Aug 29
|
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
|
|
Aug 29
|
The Zacks Analyst Blog Highlights DaVita and Illumina
|
|
Aug 28
|
ILMN's TSO Comprehensive IVD Test Secures FDA Approval as CDx
|
|
Aug 28
|
Illumina upgraded, Fiserv initiated: Wall Street's top analyst calls
|
|
Aug 28
|
2 Must-Buy Medical Stocks With Strong Momentum
|
|
Aug 28
|
FDA grants approval to Illumina’s cancer biomarker test with two CDx indications
|
|
Aug 28
|
Illumina wins FDA approval for companion diagnostic cancer test
|
|
Aug 27
|
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
|
|
Aug 26
|
Top Stock Picks for Week of August 26, 2024
|
|
Aug 26
|
Is the Options Market Predicting a Spike in Illumina (ILMN) Stock?
|
|
Aug 2
|
Buy 2 Biotech Bigwigs Set to Gain on Possible Earnings Beat
|
|
Aug 1
|
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know
|
|
Aug 1
|
Stay Ahead of the Game With Illumina (ILMN) Q2 Earnings: Wall Street's Insights on Key Metrics
|
|
Aug 1
|
Q2 2024 Standard BioTools Inc Earnings Call
|
|
Jul 30
|
Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|